SLNO Soleno Therapeutics, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
15:09
May 29
May 29
The author highlights Chris Staral's past holdings and return under Triple Helix, but this is a historical research summary and watchlist, not an active position or forward call.
LOW
15:26
May 27
May 27
The author expresses frustration with SLNO's persistent decline but confidently predicts it will eventually have a breakout day, drawing a bullish parallel to a past pattern.
15:07
Apr 09
Apr 09
Adding capital to an existing, high-conviction long position in SLNO rather than seeking new setups.
HIGH
01:26
Apr 07
Apr 07
Buyout announcement creates a clear, immediate arbitrage opportunity to go long SLNO as it will trade up toward the acquisition price.
MED
23:07
Mar 31
Mar 31
The user expresses relief or resilience regarding their positions in ABVX and SLNO.
15:02
Mar 31
Mar 31
The author suggests SLNO is poised for a potential breakout due to its association with successful M&A activity.
14:10
Mar 31
Mar 31
Author expects SLNO to be acquired next (following APLS deal) because it is the only remaining drug option in its niche after a competitor's drug was halted for safety.
HIGH
14:07
Mar 31
Mar 31
Following the APLS buyout, SLNO is a prime acquisition target with a monopoly in its indication after a competitor's drug was halted, trading at a low enterprise value relative to its projected free cash flow.
HIGH
17:20
Mar 27
Mar 27
The trader is aggressively selling puts on ABVX and SLNO, indicating a bullish outlook.
16:51
Mar 24
Mar 24
The author is aggressively accumulating shares of SLNO at current price levels.
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
05:40
Feb 26
Feb 26
Shorting the stock based on a significant downward price target revision from a sell-side analyst, implying a negative change in the fundamental outlook.
MED
About SLNO Analyst Coverage
Buzzberg tracks SLNO (Soleno Therapeutics, Inc. Common Stock) across 4 sources. 9 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (75%). 12 total trade ideas tracked.